| 1 |
34875133 | Detection of gene mutations and gene-gene fusions in circulating cell-free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis. | 2022 May |
1 |
| 2 |
33376527 | Genome-wide prioritization reveals novel gene signatures associated with cardiotoxic effects of tyrosine kinase inhibitors. | 2021 Feb |
1 |
| 3 |
30318721 | Prolonged response to sorafenib in a patient with refractory metastatic osteosarcoma and a somatic PDGFRA D846V mutation. | 2019 Jan |
1 |
| 4 |
21396851 | Prognostic prediction in patients with metastatic renal cell carcinoma treated with sorafenib based on expression levels of potential molecular markers in radical nephrectomy specimens. | 2013 Jan |
1 |
| 5 |
23243060 | Induction of endoplasmic reticulum stress by sorafenib and activation of NF-κB by lestaurtinib as a novel resistance mechanism in Hodgkin lymphoma cell lines. | 2013 Feb |
1 |
| 6 |
24324073 | Small molecule-based chemotherapeutic approach in p16-positive and -negative HNSCC in vitro. | 2013 Dec |
2 |
| 7 |
21818111 | Limited clinical activity of nilotinib and sorafenib in FIP1L1-PDGFRA positive chronic eosinophilic leukemia with imatinib-resistant T674I mutation. | 2012 Jan |
1 |
| 8 |
22294526 | Clinical activity of sorafenib in patients with advanced gastrointestinal stromal tumor bearing PDGFRA exon 18 mutation: a case series. | 2012 Mar |
1 |
| 9 |
22406992 | Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells. | 2012 May |
1 |
| 10 |
22665524 | Sorafenib inhibits many kinase mutations associated with drug-resistant gastrointestinal stromal tumors. | 2012 Aug |
3 |
| 11 |
22821509 | The role of insulin-like growth factors signaling in merlin-deficient human schwannomas. | 2012 Nov |
1 |
| 12 |
21727212 | Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2. | 2011 Jul |
1 |
| 13 |
20726440 | Identification and characterization of novel oncogenes in chronic eosinophilic leukemia and T-cell acute lymphoblastic leukemia. | 2010 |
3 |
| 14 |
19210352 | A novel FIP1L1-PDGFRA mutant destabilizing the inactive conformation of the kinase domain in chronic eosinophilic leukemia/hypereosinophilic syndrome. | 2009 Jun |
3 |
| 15 |
19212337 | FIP1L1-PDGFRalpha D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRalpha T674I eosinophilic leukemia with single agent sorafenib. | 2009 May |
1 |
| 16 |
17846009 | [Angiogenesis and renal cell carcinoma]. | 2007 Jul |
2 |
| 17 |
16645167 | Sorafenib is a potent inhibitor of FIP1L1-PDGFRalpha and the imatinib-resistant FIP1L1-PDGFRalpha T674I mutant. | 2006 Aug 15 |
1 |